Engineered nanovesicles from activated neutrophils show promise in treating infected wounds

Infectious wounds represent a critical challenge in health care, especially for diabetic patients grappling with ineffective antibiotics and escalating drug resistance. Conventional therapies often inadequately address deep tissue infections, highlighting the need for more innovative solutions.